Srinagar: Four more persons who had tested positive for COVID-19 died in Kashmir Valley on Tuesday, reports quoting officials said.
The four deaths include a 60-year-old woman from Nowhatta, a 62-year-old man from Batamaloo, a 59-year-old man from DH pora Kulgam and a 75-year-old man from Noorbagh, reported news agency KNO.
An official from SKIMS said the woman from Nowhatta, who was admitted on July 27 and the patient from Batamaloo, admitted on July 17, were suffering from multiple ailments, died on Tuesday.
He further added that the patient from Yarikhah DH Pora Kulgam was admitted on July 11 while the patient from Noorbagh Sopore was admitted on July 25 with pneumonia and other ailments.
With 33,461 deaths, the fatality count in India is now the third-biggest in the world; the country is behind the US and Brazil.
Earlier on July 25, a week after the All India Institute of Medical Sciences (AIIMS) gave its approval for conducting the human clinical trial of the COVID vaccine, a 30-year-old man was given the first dose of under trial vaccine Covaxin.
A total of 12 volunteers were called for a number of pre-tests that include blood and nasopharyngeal testing for the deadly coronavirus.
Soon after the results were found, 10 healthy individuals were selected for the vaccine to be given in phases, reports said adding, a report on their health condition will be submitted to the ethics committee, which will reviewing the entire process.
In wake of the COVID outbreak, recent research published by United Nations International Children’s Emergency Fund (UNICEF), said that at least 40 million children worldwide have missed out on early childhood education in their critical pre-school year due to the COVID closing the childcare and early education facilities.
Earlier on July 21, Council of Scientific and Industrial Research (CSIR) chief Shekhar C Mande asserted that airborne transmission of COVID is indeed a “distinct possibility” and advised people to wear masks even in enclosed spaces.
Free Press Kashmir is now on Telegram. Click here to Join.